Testing effectiveness (Phase 2)Study completedNCT01924793
What this trial is testing
An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection
Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 23